Mermaid Bio

Description: Mermaid Bio develops intrabodies via mRNA/LNP tech to target undruggable intracellular proteins, enabling breakthrough treatments for unmet medical needs.

Country: Germany

Based in: Munich

Founded: 2022

Funding Stage: Pre-Seed

Tags: ['Biopharma', 'Biotechnology', 'Nanobodies']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.